Clinical Trials on Moderate Renal Impairment in China

Total 1000 results

Sichuan Haisco Pharmaceutical Group Co., Ltd
The First Affiliated Hospital of Zhengzhou University

Completed

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Chronic Renal Impairment

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir

Renal Impairment | Hepatic Impairment

China
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Completed

A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Healthy Subjects | Subjects With Renal Impairment

China
Haisco Pharmaceutical Group Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Renal Impairment

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

Renal Impairment

China
Sunshine Lake Pharma Co., Ltd.

Completed

Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD

Renal Impairment

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment

Renal Impairment

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function

Renal Impairment

China
Chipscreen Biosciences, Ltd.

Completed

Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function

Renal Impairment

China
Haisco Pharmaceutical Group Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment

Renal Impairment

China
Haisco Pharmaceutical Group Co., Ltd.

Recruiting

A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

Renal Impairment

China
Daewoong Pharmaceutical Co. LTD.

Completed

DWP450 for Treating Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Shanghai Mental Health Center

Recruiting

Influence Factors and Cognitive Characteristics in Unipolar and Bipolar Depression:Based on the THINC-it Tool

Cognitive Impairments

China
JHM BioPharma (Tonghua) Co. , Ltd.

Recruiting

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Xinhua Hospital, Shanghai Jiao Tong University...

Terminated

Explore Efficacy of FMT Treating Childhood ASD Patients

ASD Accompanied by Moderate to Severe Gastrointestinal Symptoms

China
Galderma R&D

Completed

A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Chongqing Claruvis Pharmaceutical Co., Ltd.

Completed

A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Merz North America, Inc.

Completed

Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in China

Correction of the Moderate to Severe Nasolabial Folds

China
Guangdong Raynovent Biotech Co., Ltd

Recruiting

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

Kidney Impairment

China
Guangdong Raynovent Biotech Co., Ltd

Completed

Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease

Kidney Impairment

China
Merz North America, Inc.

Completed

Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Moderate to Severe Nasolabial Folds

Correction of Moderate to Severe Nasolabial Folds (NLFs)

China
Shanghai Greenvalley Pharmaceutical Co., Ltd.

Completed

An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease

Cognitive Impairment | Mild to Moderate Alzheimer Disease

China
Beijing Airdoc Technology Co., Ltd.
University of Notre Dame Australia

Recruiting

Software Refraction With Mobilerone Versus Retinoscopy (SRMR)

Astigmatism | Myopia | Myopia, Moderate

China
Guangzhou Women and Children's Medical Center

Completed

Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging

Failed Moderate Sedation During Procedure | Administration Related Reaction | Chloral Hydrate Adverse Reaction

China
Sunshine Lake Pharma Co., Ltd.

Completed

To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects

Hepatic Impairment

China
Shanghai 10th People's Hospital

Not yet recruiting

Effects of Intrapulmonary Percussive Ventilator on Respiratory Function

Airway Clearance Impairment

China
The University of Hong Kong

Suspended

Effectiveness of Online Group-based Nonviolent Communication Interventions

Mild to Moderate Depressive Symptoms

China
Tianjin Ever Union Biotechnology Co., Ltd.

Unknown

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Moderate and Severe Plaque Psoriasis

China
Betta Pharmaceuticals Co., Ltd.
Tigermed Consulting Co., Ltd

Terminated

Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Mild to Moderate Psoriasis

China
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Study on Human Mass Balance of SPH3127 Tablets

Primary Mild and Moderate Hypertension

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

Moderate-to-severe Plaque Psoriasis

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants

Hepatic Impairment | Healthy Participants

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Liver Function

Healthy Subjects | Hepatic Impairment

China
The Third Central Clinical College of Tianjin Medical...

Unknown

Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI (MCI)

Cognitive Impairment, Mild

China
Sun Yat-sen University

Recruiting

Study of Surgical Treatment Versus Observation in Children With Moderate Intermittent Exotropia (SOMIX)

Moderate Intermittent Exotropia

China
Xuanwu Hospital, Beijing
Wuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaborators

Recruiting

COG-REAGENT: COGnitive tRaining in patiEnts With Amnestic Mild coGnitive impairmENT

Amnestic Mild Cognitive Impairment

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects

Moderate to Severe Plaque Psoriasis

China
Huashan Hospital

Unknown

Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)

Mild Cognitive Impairment

China
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices

Moderate-to-Severe Plaque Psoriasis

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Active, not recruiting

A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis (PSO)

Moderate-to-Severe Plaque Psoriasis

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
First Affiliated Hospital of Zhejiang University

Unknown

CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI) (CTA-MCI)

Amnestic Mild Cognitive Impairment

China
Ruijin Hospital
Zhangjiagang Aoyang Hospital of Jiangsu Province

Not yet recruiting

Long Term Prospective Study of Tai Chi Intervention to Delay the Progression of Subjective Cognitive Impairment (TIPS)

Subjective Cognitive Impairment

China
Xuanwu Hospital, Beijing

Completed

Effects of Training Dose on Computerized Cognitive Training in Patients With Cognitive Impairment

Dementia | Cognitive Impairment, Mild

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Clinical Trial of Microneedle Radiofrequency Combined With Oral Isotretinoin in Moderate to Severe Acne

Moderate to Severe Acne Vulgaris

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic Impairment

Hepatic Impairment

China
Fudan University

Unknown

Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients

Neurocognitive Impairment

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic Impairment

Hepatic Impairment

China
Dongzhimen Hospital, Beijing
Shanxi Zhendong Pharmacy Co., Ltd

Completed

Efficacy and Safety of Qi Zhi Tong Luo Capsule in Vascular Cognitive Impairment

Randomized Controlled Trial | Vascular Cognitive Impairment | Qi Zhi Tong Luo Capsule

China
Changping Laboratory
Wuhan Mental Health Centre

Recruiting

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique

Major Depressive Disorder | Severe Depression | Moderate Depression

China

Clinical Trials on Moderate Renal Impairment in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations